新着情報一覧

≪元のページに戻る

NPPR SEMINAR
-The serotonin system and neuropsychopharmacology;Refinement of therapeutics-

Date: March 29, 2023
Venue: Hamamatsucho Convention Hall, Tokyo (Hybrid format)
Editor-in-Chief: Tsuyoshi Miyakawa (Fujita Health University)
Mentor, Associate Editor of NPPR: Tomiki Sumiyoshi (National Center of Neurology and Psychiatry)
Presentations: Naoyuki Hironaka (LSIM Safety Institute Corp)
Hitoshi Sakurai (Kyorin University Faculty of Medicine)
Yoshiteru Takekita (Kansai Medical University)
Special Lecture: Adrian Newman-Tancredi (Neurolixis, France)
Registration Site:
*Members Only
https://forms.gle/QaySL7YZkhx1ZYrn7
QRコード
Secretariat: c/o A & E Planning Co., Ltd.
Hitotsubashi Bekkan 4F, 2-4-4, Hitotsubashi, Chiyoda-ku, Tokyo 101-0003 Japan
E-mail:jsnp@aeplan.co.jp
Affiliated Societies: JSNP JSCNP JMSAAS AsCNP
Program: 14:00-14:05: Opening remarks
Kazutaka Ikeda (Tokyo Metropolitan Instituteof Medical Science)

14:05-14:35: Introduction Current state of NPPR
Tsuyoshi Miyakawa (Fujita Health University) / John Wiley & Sons, Inc.

14:35-15:35: Presentations
Chair:Mitsuhiko Yamada (National Center of Neurology and Psychiatry)

Serotonin and depression: Challenges of animal models
Naoyuki Hironaka (LSIM Safety Institute Corp)
abstract[PDF]


Treatments for Depression Focusing on Individual Symptoms
Hitoshi Sakurai (Kyorin University Faculty of Medicine)
abstract[PDF]


Reconsideration of antipsychotic polytherapy for schizophrenia -Pharmacotherapy in the era of BAMM-
Yoshiteru Takekita (Kansai Medical University)
abstract[PDF]



15:35-15:45: Break time

15:45-17:15: Special Lecture
Chair:Tomiki Sumiyoshi (National Center of Neurology and Psychiatry)

Serotonin 5-HT1A receptor biased agonists: next generation treatments for serotonergic disorders
Adrian Newman-Tancredi (Neurolixis, France)
abstract[PDF]


17:15-17:20: Closing remarks
Hikaru Hori (Fukuoka University)

18:00: Banquet